Copyright © 2021. Inderes Oyj. All rights reserved.
Käyttäjätili

Hei anonyymi!

Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.

Luo tili

Onko sinulla jo Inderes-tili?

Redeye updates its fair value range following the announced rights issue. As we do not yet know the full terms, the new fair value range is up for change again after the subscription price is set. There was also a slight delay on revenues, impacting when Smart Eye is estimated to reach a cash flow positive state. However, Smart Eye did also announce a great deal of new design wins, impacting our view of its market share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

Advanced eye tracking technology for vehicle integration and research, that understands, simplifies, and predicts human intentions and actions.

Smart Eye’s shares have been listed on Nasdaq First North Growth Market since 7 December 2016. The shares are included in the industrial products and services segment, and are traded under the ticker symbol SEYE.